<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Sales CS</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The aim of this study was to report the 1-week and 6-month refractive outcomes of eyes treated with a novel silicone corneal shield designed to improve visual recovery after photorefractive keratectomy (PRK).&lt;h4>Patients and methods&lt;/h4>This prospective, observational clinical trial recruited 45 myopic eyes with or without astigmatism at a university eye clinic to undergo wavefront-guided PRK followed by application of an investigational silicone corneal shield that was removed on postoperative day 4. The primary outcome measures were efficacy, predictability, and safety at the 6-month visit. The secondary end points included short-term uncorrected distance visual acuity (UDVA) and pain.&lt;h4>Results&lt;/h4>No adverse outcomes occurred using the device. At 6 months, 79.5% of eye</pubmed_abstract><journal>Clinical ophthalmology (Auckland, N.Z.)</journal><pagination>115-121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6327892</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes.</pubmed_title><pmcid>PMC6327892</pmcid><pubmed_authors>Manche EE</pubmed_authors><pubmed_authors>Sales CS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Prospective evaluation of a novel silicone corneal shield after PRK: 6-month efficacy, safety, and predictability outcomes.</name><description>&lt;h4>Purpose&lt;/h4>The aim of this study was to report the 1-week and 6-month refractive outcomes of eyes treated with a novel silicone corneal shield designed to improve visual recovery after photorefractive keratectomy (PRK).&lt;h4>Patients and methods&lt;/h4>This prospective, observational clinical trial recruited 45 myopic eyes with or without astigmatism at a university eye clinic to undergo wavefront-guided PRK followed by application of an investigational silicone corneal shield that was removed on postoperative day 4. The primary outcome measures were efficacy, predictability, and safety at the 6-month visit. The secondary end points included short-term uncorrected distance visual acuity (UDVA) and pain.&lt;h4>Results&lt;/h4>No adverse outcomes occurred using the device. At 6 months, 79.5% of eye</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019</publication><modification>2025-05-29T14:36:58.68Z</modification><creation>2025-05-29T14:36:58.68Z</creation></dates><accession>S-EPMC6327892</accession><cross_references><pubmed>30662255</pubmed><doi>10.2147/OPTH.S183120</doi></cross_references></HashMap>